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Abstract
Maternal influenza infection during pregnancy is associated with increased risk of morbidity
and mortality. However, the link between the anti-influenza immune responses and health-
related risks during infection is not well understood. We have analyzed memory T and NK
cell mediated immunity (CMI) responses in pandemic influenza A(H1N1)pdm09 (pdm09)
virus infected non-vaccinated pregnant women participating in the Norwegian Influenza
Pregnancy Cohort (NorFlu). The cohort includes information on immunization, self-reported
health and disease status, and biological samples (plasma and PBMC). Infected cases (N =
75) were defined by having a serum hemagglutination inhibition (HI) titer > = 20 to influenza
pdm09 virus at the time of delivery, while controls (N = 75) were randomly selected among
non-infected pregnant women (HI titer <10). In ELISpot assays cases had higher frequen-
cies of IFNγ+ CD8+ T cells responding to pdm09 virus or conserved CD8 T cell-restricted
influenza A virus epitopes, compared to controls. Within this T cell population, frequencies
of CD95+ late effector (CD45RA+CCR7-) and naive (CD45RA+CCR7+) CD8+ memory T
cells correlated inversely with self-reported influenza illness (ILI) symptoms. ILI symptoms
in infected women were also associated with lower numbers of poly-functional
(IFNγ+TNFα+, IL2+IFNγ+, IL2+IFNγ+TNFα+) CD4+ T cells and increased frequencies of
IFNγ+CD3-CD7+ NK cells compared to asymptomatic cases, or controls, after stimulation
with the pdm09 virus. Taken together, virus specific and functionally distinct T and NK cell
populations may serve as cellular immune correlates of clinical outcomes of pandemic influ-
enza disease in pregnant women. Our results may provide information important for future
universal influenza vaccine design.
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Introduction
During the 2009 influenza pandemic, pregnant women had an increased risk of severe influ-
enza illness and adverse pregnancy outcomes [1–3], and 12% of pregnancy-related deaths
were attributed to pandemic infection [4].
The mechanisms behind influenza infection-related mortality and morbidity in pregnancy
are still poorly understood, however it is speculated that immune modulation required for
fetal tolerance may be one of the major contributing factors [5–7]. Murine models suggest that
increased mortality and morbidity may be due to either a deficiency in cellular immunity or to
a hyper-reactive immune response to inflammatory cytokines and chemokines that govern cel-
lular infiltration and exacerbation of symptoms [8, 9]. In humans, the frequencies of mono-
cytes and dendritic cells were increased whereas natural killer (NK) and T cells frequencies
were decreased [10]. NK and T cells from pregnant women had reduced production of inter-
feron (IFN)-γ and macrophage inflammatory protein (MIP)-1β [10, 11]. Recently, CD8+ effec-
tor cells and T regulatory cells (Tregs) at the fetal-maternal interface were implicated as
modulators of fetal-immune tolerance and antiviral immunity [12–14].
Due to repeated exposure to circulating influenza strains in adults cellular immunity is
dominated by memory T cell responses. In the case of the 2009 pandemic, the new influenza
H1N1 strain was a result of reassortment between swine, human and avian influenza A strains
[15]. This strain contained several novel epitopes able to elicit naive CD4+ and CD8+ T cell
responses with potentially different dynamics to those existing from pre-established (hetero-
subtypic) memory responses against the conserved epitopes. Heterosubtypic immunity is
mainly mediated by cross-reactive cytotoxic CD8+ T cells [16–18], and pre-existing influenza-
specific CD4+ and CD8+ T cells effectively cross-reacted to the newly emerged influenza A
(H1N1)pdm09 virus [19–23].
We analyzed memory cellular immune responses in relation to influenza-like illness (ILI)
symptoms after pandemic influenza A(H1N1)pdm09 virus infection during pregnancy. Our
results showed that virus specific and functionally distinct T and NK cell populations may
serve as cellular memory-immune correlates of favorable clinical outcomes of pandemic influ-
enza disease.
Materials and methods
Study participants and design
The Norwegian Influenza Pregnancy Cohort (NorFlu) Study was established during the influ-
enza A(H1N1)pdm09 pandemic in Norway. Enrollment of pregnant women to NorFlu study
started in February 2010. Women with their last menstrual period between 1st June 2009 and
31st December 2009, and therefore pregnant during the H1N1 pandemic, were invited to par-
ticipate at the time of the routine ultrasound examination around gestational week 17–20. The
participation rate was 41%, and all participants signed a written consent.
The project protocol was reviewed and approved by the institutional review board at the
NIPH and Regional Committee for Medical and Health Research Ethics South East, Norway
(study reference numbers 2009/2165 and 2010/2937). All participants have signed a written
consent.
A nested case-control study of non-vaccinated pregnant women included infected cases
and non-infected controls during the pandemic peak in Norway (1.10.2009.– 31.12.2009.) (S1
Table). Cases (N = 75) were defined by having a serum hemagglutination inhibition (HI) titer
> = 20 to A(H1N1)pdm09 virus at the time of delivery. Controls (N = 75) were randomly
selected among non-infected pregnant women with an HI titer<10 at delivery. Pre-existing
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protective HI titers to the influenza A(H1N1)pdm09 virus were low in the Norwegian popula-
tion prior to the pandemic, including women of fertile age [24].
Outcomes and symptom score
Cases were further categorized based on self-reported questionnaires as 1) symptomatic–
reporting influenza-like illness (ILI) symptoms during the pandemic peak (October–Decem-
ber 2009): fever and cough or fever and sore throat, or 2) asymptomatic–reporting no ILI
symptoms. Further, a symptom score was designed by totaling the weight for each of the
canonical ILI symptoms: fever, cough, sore throat, rhinitis, headache, and myalgia, with a
weight of 1, 4 or 6, if the reported duration of symptoms was 0–2, 3–5 or more than 5 days,
respectively. Self-report of many symptoms, more severe illness and longer duration of illness
were associated with higher HI titers (p<0.05 for all comparisons, manuscript in preparation).
Pandemic virus and epitope libraries
In all ELISpot and flow cytometry assays a H2O2 inactivated A/California/07/2009(H1N1)
pdm09 (pdm09) virus was used at 75 hemagglutination units (HAU) for stimulation of PBMC
[25]. In addition, a total of seven influenza A epitope libraries were used as previously
described [26]. In brief, conserved influenza A epitopes were divided in four universal influ-
enza A peptide libraries according to MHC class I and II restriction (uCD8 and uCD4, respec-
tively). The libraries were divided according to epitope origin: 1) external viral proteins–
uCD8e and uCD4e, and 2) internal viral proteins–uCD8i and uCD4i. Peptides unique for the
pandemic A(H1N1)pdm09 virus were similarly grouped in three libraries: pCD4e, pCD8i and
pCD4i (pCD8e library did not include unique peptides; more details in [26]).
Ex vivo enzyme-linked IFNγ/Granzyme B immunospot assay (ELISpot)
ELISpot assays were performed as previously described [26], with additional information pro-
vided in Supplementary Materials and Methods (S1 and S2 Figs, S1 and S2 Files).
Flow cytometry assays
Flow cytometry assays, and gating strategies, were performed as previously described [26–28],
with additional information provided in Supplementary Materials and Methods (S7 and S8
Figs, S2 Table, S1 and S2 Files). Cells were analyzed on a BD LSRII flow cytometer using FACS
Diva and FlowJo (TreeStar) software. Cells were gated according to forward- and side-scatter
plots, and 40,000 CD4+ T cells, or 25,000 CD3- cells, were acquired. All functional values are
presented as a fold change over a negative control, assuming synergistic rather than an additive
effect [29].
Statistical analyses
The frequencies of antigen-specific T cells in ELISpot assays between exposure groups were
compared using Wilcoxon rank-sum test. The Kruskal-Wallis test followed by Dunn’s ‘post-
hoc’ test was used to analyze differences in antigen-specific T cells frequency fold change
among the three exposure groups in flow cytometry experiments.
Presence of individual ILI symptom and the frequency of IFNγ and Granzyme B producing
PBMC, and frequency of T and NK cells analyzed by flow cytometry were correlated using
point biserial correlation (i.e. to correlate a dichotomous and a continuous variable). Total
symptom score and cell frequencies were analyzed by Spearman rank correlation (i.e. to corre-
late two continuous variables).
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Results
Frequency of IFNγ-secreting CD8+ T cells was correlated with
asymptomatic infection
Cases had a higher median frequency of IFNγ-secreting cells compared to controls after stimu-
lation with the whole inactivated pdm09 virus (p = 0.0169), or the uCD8i epitope library
(p = 0.0037), but not after stimulation with the uCD4i epitope library (Fig 1A, 1B and 1C). Fur-
ther analysis of cases, based on reported illness symptoms, showed a higher frequency of
IFNγ-secreting cells in cases reporting no symptoms (N = 37) compared to those who experi-
enced ILI symptoms (N = 38) (p = 0.0287), after stimulation with the uCD8i epitope library
(Fig 1F). The frequency of this cell population was inversely correlated with the ILI symptoms
(rho = -0.2303, p = 0.0468), suggesting a protective role of these cells against the symptomatic
pdm09 infection. The levels of anti-pdm09 virus antibodies were comparable between symp-
tomatic and asymptomatic cases (p = 0.5180, data not shown).
In contrast, in infected symptomatic women (N = 38), the total symptom score during ILI
had modest positive correlation with the frequency of IFNγ secreting cells after stimulation
with universal internal CD4 epitopes (uCD4i, rho = 0.3173, p = 0.0491) (Fig 1E). Collectively,
our results suggest somewhat opposing roles of IFNγ-secreting T cells: protective effect against
the symptomatic illness mediated by cells responding to the universal CD8 internal influenza
Fig 1. Frequency of IFNγ secreting PBMC measured in ELISpot assays after stimulation with inactivated pdm09 virus. (A, D), uCD4i, (B, E), and
uCD8i (C, F) epitope library. Top row represents differences among cases and controls (A, B, C), bottom row represents differences between asymptomatic
and symptomatic cases (D, E, F). Inlet in figure A zooms on the range of cell frequencies presented on a linear scale (p values, Wilcoxon-Mann-Whitney test).
https://doi.org/10.1371/journal.pone.0188055.g001
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A epitopes, while there was a potentially symptoms induction by cells stimulated by the univer-
sal CD4 internal viral epitopes.
Different populations of memory T cells were inversely correlated with ILI
symptoms
After stimulation with the pdm09 virus we observed increased frequency fold change of
CD95+ CD4+ and CD8+ naive T cells among asymptomatic cases compared to those reporting
symptoms (S3A and S3B Fig). The frequency of CD95+CD4+ naive T cells was inversely corre-
lated with most self-reported ILI symptoms: fever (rho = -0.4794, p = 0.0603), cough (rho =
-0.3795, p = 0.1471), and sore throat (rho = -0.5207, p = 0.0380). Similarly, negative correla-
tions were observed between the frequency of CD95+CD8+ naive T cells and self-reported ILI
symptoms: fever (rho = -0.4320, p = 0.0947), cough (rho = -0.3544, p = 0.1781), and sore throat
(rho = -0.5115, p = 0.0428). In addition, the frequency of CD95+CD8+ naive T cells was nega-
tively correlated with self-reported fever (rho = -0.4844, p = 0.0572), after stimulation with
conserved influenza A peptides (uCD8i) (S4 Fig).
Symptomatic cases had a reduced frequency of CD95+CD8+ central memory T cells (Tcm)
compared to asymptomatic cases (p = 0.0929). Late effector memory CD8+ T cells (CD8+
Temra) that express CD95 marker were significantly reduced in symptomatic cases compared
to asymptomatic cases (p = 0.0148), after stimulation with the pdm09 virus (Fig 2B), which
was not observed for CD8+ nor CD107a+CD8+ Temra cells (Fig 2A and 2C). The frequency of
CD95+CD8+ Temra, but not CD107a+CD8+ Temra cells, was inversely correlated with self-
reported fever (r = -0.5794, p = 0.0187), headache (r = -0.4951, p = 0.0798), cough (r = -0.4951,
p = 0.0512), and sore throat (r = -0.606, p = 0.0128), indicating a protective effect against
symptomatic ILI during pregnancy. Furthermore, after stimulation with the uCD8i epitope
library, the frequency of CD95+CD8+ Temra cells was inversely correlated with fever (r =
-0.5126, p = 0.0423), suggesting cell-mediated cross-protection against the symptomatic pan-
demic influenza A(H1N1)pdm09 virus infection.
Multifunctional CD4+ and CD8+ T cells were associated with favorable
ILI symptoms
We analyzed the effector functions of the CD4+ and CD8+ T cell responses after stimulation
with the pdm09 virus or uCD8i peptides. We observed increased frequency of IFNγ+ and
Fig 2. CD95+ CD8+ Temra cells as cellular immune correlates of protection against symptomatic ILI after exposure to pdm09 virus in pregnancy.
PBMC samples were stimulated ex vivo, y-axis in all panels shows cell frequency fold change over unstimulated control: (A) CD8+ Temra, (B) CD95+ CD8+
Temra, (C) CD107+ CD8+ Temra (p vlaues, Dunn’s Kruskal-Wallis post hoc test).
https://doi.org/10.1371/journal.pone.0188055.g002
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MIP1β+ CD4+ T cells in controls and asymptomatic cases compared to symptomatic cases
after stimulation with the pdm09 virus (2.5 and 1.5 fold change increase, respectively) (Fig
3A). In addition, median fold changes in frequency of IL2+CD4+ and TNFα+CD4+ T cells
were lower in symptomatic cases compared to asymptomatic cases (Fig 3A). The increase in
frequency fold change of IFNγ+TNFα+CD4+ T cells was significantly higher in asymptomatic
cases compared to symptomatic cases (p = 0.0253), after stimulation with the pdm09 virus (Fig
3A), which was also observed in the IL2+IFNγ+ and IL2+IFNγ+TNFα+ CD4+ T cell compart-
ments (p = 0.0215 and p = 0.0250, respectively).
In the CD8+ T cell compartment single cytokine producing cells: IFNγ+, IL2+, TNFα+, or
MIP1β+ had lower frequency fold changes in symptomatic cases compared to asymptomatic
cases after stimulation with the pdm09 virus (Fig 3B). The frequency of triple cytokine produc-
ing IL2+IFNγ+TNFα+ CD8+ T cells was significantly higher in asymptomatic compared to
symptomatic cases (p = 0.0447). Frequency changes of single cytokine producing (IFNγ+,
MIP1β+, TNFα+), and double cytokine producing (IFNγ+TNFα+) CD8+ T cells specific for
uCD8i epitopes were higher in asymptomatic cases compared to symptomatic cases (~3.5, 2,
~2, and>4 fold, respectively) (Fig 3C). Stimulation with HLA class I restricted CMV peptides
did not induce significant changes in comparable CD8+ T cell populations (Fig 3D), further
strengthening the observation that the effector CD8+ T cell responses were influenza A specific
with a potential to provide heterosubtypic immunity since the uCD8i peptide epitope library
represents a collection of conserved epitopes present in influenza A strains spanning the
period from 1934 to 2009 [26].
Different NK cell populations were associated with ILI symptoms
The cell frequencies of the total NK and CD107a+ NK cells were comparable among three
groups of women (Fig 4A and 4B). Cases had higher frequencies of CCR7+ and IFNγ+ NK
cells, with symptomatic cases having increased frequency of IFNγ+ NK cells compared to
asymptomatic cases (p = 0.1689), or controls (p = 0.0236) after stimulation with the pdm09
virus (Fig 4C and 4D).
The control group had the highest cell frequency fold change of CD16+CD56+ NK cells
after stimulation with the whole inactivated pdm09 virus compared to symptomatic cases
(p = 0.0619), which was also observed in CCR7+CD16+CD56+ and CD107a+CD16+CD56+
(p = 0.0580) NK cell compartments (Fig 4E). An almost 2.5 fold increase in median cell fre-
quency of IFNγ+CD16+CD56+ NK cells was observed in half of the asymptomatic cases com-
pared to controls, while this cell population was almost completely absent in symptomatic
cases. In contrast, symptomatic cases had a slightly increased median frequency of
IFNγ+CD16+CD56- NK cells, compared to asymptomatic cases or controls.
Finally, we analyzed the possible correlations in cell frequencies among effector CD4+ and
CD8+ T cells and different populations of NK cells (S5 Fig). In the control group, prominent
negative correlations within the NK cell compartment were observed: CD16+CD56- NK cells
were negatively correlated with CD16-CD56- and CD107a+CD16-CD56- NK cells. We also
found negative correlations between CD16+CD56- NK and IL2+CD4+ T cells. Among asymp-
tomatic cases, more positive correlations were observed between CD4+ and CD8+ T cell com-
partments, and increasing number of negative correlations between cells in the CD16-CD56-
NK and CD8+ T cell compartments. In contrast, symptomatic cases showed multiple positive
correlations between cells in the IFNγ+ and CD107+CD16-CD56- NK and IFNγ+TNFα+CD4+
T cell compartments. Also, cell frequencies of the CD107a+CD16+CD56+ and
CD107a+CD16+CD56- NK and TNFα+, IFNγ+ and TNFα+IFNγ+ CD4+ T cell compartments
were positively correlated, suggesting a possible mechanism of reinforcing the inflammatory
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loop between innate and adaptive CMI responses. The overall differences in cellular correla-
tions of the CMI response networks between the three groups of pregnant women were statis-
tically significant (p<0.0001, S5 Fig), indicating an association between altered CMI responses
and disease severity in pregnancy.
Discussion
We analyzed the relationship between T and NK cell-mediated immunity and disease severity
in pregnant women infected with influenza A(H1N1)pdm09 virus during the 2009 pandemic
in Norway. Influenza infected women without ILI symptoms had a higher magnitude of IFNγ
producing CD8+ T cells, compared to those reporting symptoms, as measured in ELISpot
assays after stimulation with the pdm09 virus or peptides representing conserved CD8+ T cell
epitopes (uCD8i). These antigen-specific CD8+ T cells are of particular interest due to their
Fig 3. Effector functions of CD4+ and CD8+ T cells. Median cell frequency fold changes of (A) CD4+, (B) CD8+ T cells after stimulation with the pdm09
virus, and median CD8+ T cell frequency fold change after stimulation with (C) uCD8i, (D) CMV epitopes. Dotted lines in graphs represent the fold change
level (p values, Dunn’s Kruskal-Wallis post hoc test).
https://doi.org/10.1371/journal.pone.0188055.g003
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ability to provide cross-protective immunity against a range of influenza viruses [20, 21, 30,
31], and may provide the basis for universal influenza vaccine development [16, 32]. The
inverse correlation observed between reported symptoms and frequency of IFNγ-secreting T
cells indicates a putative protective effect of this cell population against symptomatic pandemic
influenza illness during pregnancy. A similar observation has been reported previously: higher
frequencies of pre-existing T cells specific for influenza A CD8 epitopes were found in individ-
uals who reported mild ILI symptoms [21]. Nevertheless, it must be noted that the samples in
our study were collected at the time of delivery, which means that the average time interval
between exposure to pandemic influenza A(H1N1)pdm09 virus and the collection of the
blood samples was 7.5 months. However, due to the fact that the average human is exposed on
multiple occasions to influenza infection during their lifetime, and that our universal CD8+ T
cell epitope library contains the most conserved influenza A epitopes, it is reasonable to
assume that some, if not most, of the IFNγ+ CD8+ T cells, responding to such epitopes, were
present before the pandemic and thus may have provided cross-protective immunity against
the 2009 pandemic strain.
We further examined the association between different memory T cell subtypes and disease
severity after exposure to the A(H1N1)pdm09 virus. Our results suggest that the CD95+CD8+
late effector memory T cells (Temra) may serve as a potential memory-immune correlate of
protection against symptomatic pandemic influenza A illness in pregnant women. The finding
that CD95+ Temra cells after stimulation with both pdm09 virus and the uCD8i epitope library
were inversely correlated with fever, suggests a cross-protective role for this cell population
against the pandemic virus as well as a range of other influenza A strains. Previous reports
have identified various pre-existing CD4+ and CD8+ T cell populations as cellular immune
correlates of protection against symptomatic influenza disease. Wilkinson and coworkers,
identified IFNγ+CD4+ memory T cells (CD27+CD45RO-CD4+) with cytotoxic potential
Fig 4. Cell frequency fold change among controls, asymptomatic and symptomatic cases after the pdm09 virus stimulation. (A) total NK cells, (B)
CD107a+ NK cells, (C) CCR7+ NK cells, (D) IFNγ+ NK cells, (E) radar graph of specific NK cell populations characterized by the surface markers CD16 and
CD56, and positive for CD107a, CCR7 or IFNγ expression. Dotted lines in graph E represent the fold change level (p values, Dunn’s Kruskal-Wallis post hoc
test in D, factorial ANOVA in E).
https://doi.org/10.1371/journal.pone.0188055.g004
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against conserved CD4 epitopes in a human challenge study [23]. In contrast, Sridhar et al.
identified pre-existing IFNγ+CD8+ Temra cells, specific for conserved influenza A viral epi-
topes, as cellular immune correlates of protection against community acquired symptomatic
pandemic influenza [21].
Abundant expression of the CD95 marker on naive memory T cells was recently described
on so-called memory stem T cells (TSCM), which were characterized by enhanced self-renewal
and multipotency, increased proliferative capabilities and rapid acquisition of effector func-
tions after antigen stimulation [33]. We observed increased frequencies of CD95+CD4+ and
CD95+CD8+ naive memory T cells in asymptomatic compared to symptomatic cases. Both
CD95+ naive memory CD4+ and CD8+ T cells, which are phenotypically similar to TSCM, were
inversely correlated with occurrence of ILI symptoms in A(H1N1)pdm09 virus exposed preg-
nant women. Therefore it is warranted to further investigate TSCM cells role in CMI against
influenza and implications for the design of T cell-based influenza vaccine.
Both the magnitude and quality of antiviral CD4+ and CD8+ T cell responses are critical for
the control of viral infection and the course of (symptomatic) illness. We observed effector
responses in the CD4+ T cell compartment after stimulation with the A(H1N1)pdm09 virus,
which was in accordance with a previous report showing that pregnant women can elicit
robust T cell responses against influenza A viruses [34]. Changes in the frequency of multi-
functional IL2+IFNγ+, IFNγ+TNFα+ and IL2+IFNγ+TNFα+ CD4+ T cells were higher in
asymptomatic cases as compared to both symptomatic cases and controls. Multiple-cytokine
producing CD4+ T cells were previously described as highly potent cytokine producers that
could provide better co-stimulatory functions to CD8+ T cells and B cells: characteristics that
enable superior antiviral responses [35]. Our results reaffirm the notion that the characteristics
of multi-cytokine producing CD4+ T cells constitute an important aspect of the complex cellu-
lar immunity network that provides cues for illness severity during pregnancy.
Effector functions in the CD8+ T cell compartment were characterized by reduced changes
in frequency of IFNγ+CD8+ T cells in cases compared to controls, and generally lowered fre-
quencies of CD8+ T cells among symptomatic compared to asymptomatic cases. Multifunc-
tional CD8+ T cells were more prominent in asymptomatic cases compared to controls or
symptomatic cases. We observed more than a 4 fold change in IFNγ+TNFα+ CD8+ T cell fre-
quencies after stimulation with conserved CD8 epitopes in asymptomatic compared to symp-
tomatic cases, which was also true for IFNγ+ and TNFα+ CD8+ T cell populations. These CD8+
T cell populations, specific for the conserved CD8 epitope library, could provide heterosubty-
pic cellular immunity against different influenza A infections [36]. In general, asymptomatic
cases had more robust multifunctional CD4+, and to some extent CD8+ T cell responses, as
compared to their symptomatic counterparts, which could partly explain the difference in the
symptomatic course of illness, and points towards the growing evidence of crucial role(s) of
CD4+ T cells in anti-influenza response [23, 37].
Finally, we analyzed the effector functions of circulating NK cells. Cases had higher changes
in frequency of CCR7+ and IFNγ+ NK cells compared to controls. A notable feature was a
steady increase in cell frequency in the IFNγ+ NK cell compartment when moving from con-
trols to asymptomatic to symptomatic cases after stimulation with the pdm09 virus. Our
results are in accordance with previous report showing increased IFNγ+ NK cell frequencies in
pregnant women following influenza infection or vaccination [34]. We further dissected the
NK cell compartment according to expression of CD16 and CD56 markers. Compared to con-
trols, cases had no CCR7+CD16+CD56+ NK cells. We observed more than 2 fold increase of
IFNγ+CD16+CD56+ NK cell frequency in asymptomatic cases compared to controls, albeit
only in half of the analyzed asymptomatic cases, while this NK cell population was completely
absent in symptomatic cases. Double positive NK cells are characterized by a permanent state
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of readiness for immediate response, and they are implicated in antibody-dependent cellular
cytotoxicity (ADCC) and can rapidly produce IFNγ upon activation [38]. All these features
implicate IFNγ+CD16+CD56+ NK cells as part of a cellular network of immune correlates of
protection.
Strengths of our study are reflected in the uniqueness of the biobank that contains plasma,
PBMC, DNA and RNA from women pregnant during the pandemic peak in Norway. Also,
extensive data collection about the immunization, health and disease status through national
health registries and questionnaires allows analyzing associations between self-reported ILI
symptoms and CMI. However, limitations are reflected in an inability to establish baseline
responses due to unpredictable occurrence of the pandemic influenza and the timing of preg-
nancy and sample collection; furthermore the study had limited samples available. Samples
were from the peripheral blood, thus the overall picture of cellular immune effector functions
and memory does not reflect tissue-specific immunity (e.g. upper airways or lungs). Finally,
most women were exposed during the first trimester of pregnancy whereas blood samples
were collected at birth. The observed cell frequencies of antigen specific CD4 and CD8 T cells
and NK cells could have been affected by the hormonal status at labor, as it was noted previ-
ously that a rise in progesterone and estradiol levels could negatively influence cell frequencies
of adaptive immunity [5, 6]. Therefore it is of great importance to continue efforts to analyze
CMI in different trimesters of pregnancy specifically in the acute phase of influenza A
infection.
Influenza infection in pregnancy is a complex, challenging and clinically important prob-
lem. In a community acquired infection setting, we observed qualitatively and quantitatively
different CMI responses against the pandemic A(H1N1)pdm09 virus in symptomatic and
asymptomatic pregnant women, which are probably major determinants of illness progression
and severity. Furthermore, we have identified several antigen-specific T cell populations which
potentially can be used as cellular immune correlates of cross-protection against different
influenza A viruses during pregnancy. Understanding interactions between various immune
cell types (e.g. T and NK cells) of the maternal immune system and the virus, and influence of
immune and hormonal signals from maternal-fetal barrier, both systemically and locally, may
lead to improved disease management and prevention strategies. Furthermore, our data
expand the growing immunological evidence-based impetus for the design of universal influ-
enza vaccines to induce cross-reactive T cells that could confer protection against emerging
influenza viruses.
Supporting information
S1 Fig. Frequency of IFNɣ secreting PBMC among cases and controls. PBMC were stimu-
lated with various influenza A antigen libraries: (A) pCD4i, (B) pCD4e, (C) pCD8i, (D)
uCD4e, (E) uCD8e (p values, Wilcoxon-Mann-Whitney test).
(TIF)
S2 Fig. Frequency of IFNγ secreting PBMC among asymptomatic and symptomatic cases.
PBMC were stimulated with various influenza A antigen libraries: (A) pCD4i, (B) pCD4e, (C)
pCD8i, (D) uCD4e, (E) uCD8e (p values, Wilcoxon-Mann-Whitney test).
(TIF)
S3 Fig. Phenotypes of memory T cells after stimulation with pdm09 virus. Radar graphs
represent median cell frequency fold change of (A) CD4+, (B) CD8+ memory T cells subsets.
Dotted lines in graphs represent the fold change level (p values, Kruskal-Wallis test).
(TIF)
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S4 Fig. Phenotypes of CD8+ memory T cells after stimulation with peptide epitopes. Radar
graphs represent median cell frequency fold change after stimulation with (A) uCD8i, (B)
CMV epitopes. Dotted lines in graphs represent the fold change level (p values, Kruskal-Wallis
test).
(TIF)
S5 Fig. Circos diagrams of correlations among effector CD4+ and CD8+ T cells, and NK
cells after stimulation with pdm09 virus. (A) controls, (B) symptomatic cases, (C) asymp-
tomatic cases. Top left diagram represents visual legend for the segments orientation in each
diagram–one segment corresponds to a particular immune cell subset and antigen stimulation
combination, whereas left and right semicircles designate T and NK cell compartments,
respectively. For clarity correlation coefficient values between -0.5 and +0.5 were not pre-
sented, values between 0.5 and 0.7 in light color, and values between 0.7 and 1 in dark color
(see the bar at the top left panel) (p values, Steiger’s test).
(TIF)
S6 Fig. Circos diagrams of correlation of IFNγ and Granzyme B PBMC compartments
after stimulation with pdm09 and various influenza A antigens. (A) controls, (B) symptom-
atic cases, (C) asymptomatic cases. Top left diagram represents visual legend for the segments
orientation at each diagram–one segment corresponds to a particular PBMC and antigen stim-
ulation combination, whereas left and right semicircles designate Granzyme B and IFNγ
PBMC compartments, respectively. For clarity correlation coefficient values between -0.25 and
+0.25 were not presented, values between 0.25 and 0.5 in light color, and values between 0.5
and 1 in dark color (see the bar at the top left panel) (p values, Steiger’s test).
(TIF)
S7 Fig. Gating strategy to define memory T-cell populations using CD45RA and CCR7
markers. SSC-A–side scatter area, FSC-A–forward scatter area, Live/Dead–aqua live/dead via-
bility dye.
(TIF)
S8 Fig. Gating strategy to define NK-cell populations using CD7, CD16 and CD56 mark-
ers. SSC-A–side scatter area, FSC-A–forward scatter area, Live/Dead–aqua live/dead viability
dye.
(TIF)
S1 Table. Demographic and other characteristics of cases and controls.
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S1 File. Supporting information. Additional details regarding Materials and Methods, and
Results section.
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